Uses of coercion in addiction treatment: Clinical aspects

American Journal on Addictions

Volumn 17, Issue 1, 2008, Pages 36-47

  Sullivan, Maria A ^a,m   Birkmayer, Florian ^b   Boyarsky, Beth K ^c   Frances, Richard J ^d   Fromson, John A ^e   Galanter, Marc ^d   Levin, Frances R ^a   Lewis, Collins ^f   Nace, Edgar P ^g,h   Suchinsky, Richard T ^h   Tamerin, John S ^h,i   Tolliver, Bryan ^j   Westermeyer, Joseph ^k,l  

^a New York State Psychiatric Institute ^*  (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Committee for Physician Health ^*  (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h Cornell/Weil School of Medicine ^*

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

^l UNIVERSITY OF MINNESOTA   (United States)

^m NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIRAM;

ALCOHOLISM; BEHAVIOR THERAPY; CULTURAL ANTHROPOLOGY; DRUG DEPENDENCE; ETHNICITY; HUMAN; PERSUASIVE COMMUNICATION; PHILOSOPHY; PSYCHOTHERAPY; REVIEW; TREATMENT INDICATION;

EID: 38549143059     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490701756369     Document Type: Review

References (78)

1. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51:390-395.
2. Miller NS, Flaherty JA. Effectiveness of coerced addiction treatment (alternative consequences): A review of the clinical research. J Subst Abuse Treat. 2000;18:9-16.
3. Westermeyer J. Monitoring recovery from substance abuse: Rationales, methods and challenges. Advances in Alcohol & Substance Abuse 1988;8:93-105.
4. Boyarsky BK, Dilts S, Frances RJ, et al. GAP Committee on Addictions. Responsibility and choice in substance use and addiction. Psychiatr Serv. 2002;53:651-782.
5. Incidardi JA. Compulsory treatment in New York: A brief narrative history of misjudgment, mismanagement, and misrepresentation. Journal of Drug Issues. 1988;18:547-560.
6. Taxman FS, Messina NP. Civil commitment: One of many coerced treatment models. In: Leukefeld CG, Tims F, Farabee D, eds. Clinical and Policy Responses to Drug Offenders. Lexington, Ky.: Center on Drug and Alcohol Research; 2002.
7. Hall KT, Appelbaum PS. The origins of commitment for substance abuse in the United States. J Am Acad Psychiatry Law. 2002;30:33-45; discussion 46-48.
8. Andre C, Jaber-Filho JA, Carvalho M, Julliien C, Hoffman A. Predictors of recovery following involuntary hospitalization of violent substance abuse patients. Am J Addict. 2003;12:84-89.
9. Johnson VE. Intervention: How to Help Someone Who Doesn't Want Help. Minneapolis, Minn.: Johnson Institute Books; 1986.
10. Loneck B, Garrett JA, Banks SM. A comparison of the Johnson Intervention with four other methods of referral to outpatient treatment. Am J Drug Alcohol Abuse. 1996;22:233-246.
11. Gallegos KV, Talbott GD. Physicians and other health professionals. In: Lowinson JH, Ruiz P, Millman R, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. Baltimore, Md.: Williams & Wilkins, 1997:744-754.
12. Fromson JA. Addressing clinician performance problems as a systems issue. In: Youngberg B, Hatlie MJ, eds. The Patient Safety Handbook. Boston, Mass.: Jones and Bartlett; 2004.
13. King G, Ellinwood Jr. EH. Amphetamines and other stimulants. In: Lowinson JH, Ruiz P, Millman R, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. Baltimore, Md.: Williams & Wilkins; 1997:207-223.
14. Hall WC, Talbert RL, Ereshefsky L. Cocaine abuse and its treatment. Pharmacotherapy. 1990;10:47-65.
15. Washton A. Structured outpatient group therapy. In: Lowinson JH, Ruiz P, Millman R, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. Baltimore, Md.: Williams & Wilkins; 1997:440-448.
16. Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL. Monitoring opiate abuse in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol. 2000;24:509-521.
17. DuPont RL, Baumgartner WA. Drug testing by urine and hair analysis: Complementary features and scientific uses. Forensic Sci Int. 1995;70:63-76.
18. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Mandatory guidelines for federal workplace drug testing programs. Fed Regist. 2004 (April 13);69(71):19644-19673.
19. Wasserman DA, Korcha R, Havassy BE, Hall SM. Detection of illicit opioid and cocaine use in methadone maintenance treatment. Am J Drug Alcohol Abuse. 1999;25:561-571.
20. Ehrenreich H, Mangholz A, Schmitt M, et al. OLITA: An alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach. Eur Arch Psychiatry Clin Neurosci. 1997;247:51-54.
21. Lawental E, McLellan AT, Grissom GR, Brill P, O'Brien C. Coerced treatment for substance abuse problems detected through workplace urine surveillance: Is it effective? J Subst Abuse. 1996;8:115-128.
22. Reading E. Nine years experience with chemically dependent physicians: The New Jersey experience. MD Medical Journal. 1992;41:325-329.
23. Gallegos K, Lubin B, Bowers C, Blevins J, et al. Relapse and recovery: Five to ten year follow study of chemically dependent physicians - the Georgia experience. MD Medical Journal. 1992;41:315-319.
24. Shore J. The Oregon experience with impaired physicians on probation. JAMA. 1987;257:2931-2934.
25. McCarthy JJ, Borders OT. Limit setting on drug abuse in methadone maintenance patients. Am J Psychiatry. 1985;142:1419-1423.
26. Liebson IA, Tommasello A, Bigelow GE. A behavioral treatment of alcoholic methadone patients. Ann Intern Med. 1978;89:342-344.
27. Dolan MP, Black JL, Penk WE, et al. Contracting for treatment termination to reduce illicit drug use among methadone maintenance treatment failures. J Consult Clin Psychol. 1985;53:549-551.
28. Nolimal D, Crowley TJ. Difficulties in a clinical application of methadone-dose contingency contracting. J Subst Abuse Treat. 1990;7:219-224.
29. Saxton AJ, Calsyn DA, Kivlahan DR, et al. Outcome of contingency contracting for illicit drug use in a methadone maintenance program. Drug Alcohol Depend. 1993;31:205-214.
30. Stitzer ML, Bickel WK, Bigelow GE, et al. Effect of methadone dose contingencies on urinalysis test results of polydrug abusing methadone maintenance patients. Drug Alcohol Depend. 1986;18:341-348.
31. Silverman K, Higgins ST, Brooner RK, et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996;53:409-415.
32. Budney AJ, Higgins ST, Radonovich KJ, et al. Adding voucher-based incentives to coping-skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000;68:1051-1061.
33. Higgins ST, Wong CJ, Badger GJ, et al. Contingency reinforcement increases cocaine abstinence during outpatient treatment and one year of follow-up. J Consult Clin Psychol. 2000;68:64-72.
34. Wexler HK. The promise of prison-based treatment for dually diagnosed inmates. J Subst Abuse Treat. 2003;25:223-231.
35. Melnick G, De Leon G, Thomas G, Kressel D, Wexler HK. Treatment process in prison therapeutic communities: Motivation, participation, and outcome. Am J Drug Alcohol Abuse. 2001;27:633-650.
36. Goodwin DW, Gabrielli Jr WF. Alcohol: Clinical aspects. In: Lowinson JH, Ruiz P, Millman R, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. Baltimore, Md.: Williams & Wilkins; 1997:142-148.
37. Brewer C. Patterns of compliance and evasion in treatment programs which include supervised disulfiram. Alcohol Alcohol. 1986;21:385-388.
38. Galanter M. Network Therapy for Alcohol and Drug Abuse: A New Approach in Practice. New York: Basic Books; 1993.
39. Platt JJ, Buhringer G, Kaplan CD, Brown BS, Taub DO. The prospects and limitations of compulsory treatment for drug addiction. Special issue: A social policy analysis of compulsory treatment for opiate dependence. Journal of Drug Issues. 1988;18:505-525.
40. Hartjen CA, Mitchell SM, Washburne NF. Sentencing to therapy: Some legal, ethical, and practical issues. Journal of Offender Counseling, Services and Rehabilitation. 1981;6:21-39.
41. Anglin MD, Prendergast M, Farabee D. The effectiveness of coerced treatment for drug-abusing offenders. Paper presented at the Office of National Drug Control Policy's Conference of Scholars and Policy Makers, Washington, DC, March 23-25, 1998.
42. Leshner AI. Drug addiction research: Moving toward the 21st century. Drug Alcohol Depend. 1998;51:5-7.
43. Anglin MD, Maugh TH. Overturning myths about coerced drug treatment. California Psychologist. 1992;25:19-22.
44. Salmon RW, Salmon RJ. The role of coercion in rehabilitation of drug abusers. International Journal of the Addictions. 1983;18:9-21.
45. Mill JS. 1859 On Liberty. In: The Six Great Humanistic Essays of John Stuart Mill (A. W. Levi, Ed.). New York: Washington Square Press; 1963:127-240.
46. Kozlowski LT, Skinner W, Kent C, Pope MA. Prospects for smoking treatment in individuals seeking treatment for alcohol and other drug problems. Addict Behav. 1989;14:273-278.
47. Pletcher VC. Nicotine treatment at the drug dependency program of the Minneapolis VA Medical Center: A program director's perspective. J Subst Abuse Treat. 1993;10:139-145.
48. Ker M, Leischow S, Markowitz IB, Merikle E. Involuntary smoking cessation: A treatment option in chemical dependency programs for women and children. J Psychoactive Drugs. 1996;28:47-60.
49. Anglin MD. The efficacy of civil commitment in treating narcotics addiction. Special issue: A social policy analysis of compulsory treatment for opiate dependence. Journal of Drug Issues. 1988;18:527-545.
50. Anglin MD, Hser Y. Criminal justice and the drug-abusing offender: Policy issues of coerced treatment. Behavioral Sciences and the Law. 1991;9:243-267.
51. Jonsen AR, Siegler M, Winslade WJ. Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine. New York: McGraw-Hill; 1998.
52. Janssens MJ, Van Rooij MF, ten Have HA, Kortmann FA, Van Wijmen FC. Pressure and coercion in the care for the addicted: Ethical perspectives. J Med Ethics. 2004;30:453-458.
53. Beauchamp TL. Philosophical Ethics. New York: McGraw-Hill; 1982.
54. Frankena WK. Ethics. Upper Saddle River, NJ: Prentice Hall; 1973.
55. Singer P. A Companion to Ethics. Malden, Mass.: Blackwell; 1993.
56. Moreno JD. Neuroethics: An agenda for neuroscience and society. Nature Reviews Neuroscience. 2003;4:149-153.
57. National Bioethics Advisory Commission. Research Involving Persons with Mental Disorders That May Affect Decision-making Capacity. Rockville, Md.: National Bioethics Advisory Commission: 1999.
58. Monahan J, Swarz M, Bonnie RJ. Mandated treatment in the community for people with mental disorders. Health Aff. 2003;22:28-38.
59. Geller JL. Clinical guidelines for the use of involuntary outpatient treatment. Hospital and Community Psychiatry. 1990;41:749-755.
60. Rubenstein LS. Treatment of the mentally ill: Legal advocacy enters the second generation. Am J Psychiatry. 1986;143:1264-1269.
61. NY State Office of Mental Health. Kendra's Law: Final Report on the Status of Assisted Outpatient Treatment. New York: Office of Mental Health; 2005.
62. Swartz MS, Swanson JW, Wagner RH, et al. Can involuntary outpatient commitment reduce hospital recidivism? Am J Psychiatry. 1999;156:1968-1975.
63. Swartz MS, Swanson RH. Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: What's in the data? Can J Psychiatry. 2004;49:585-591.
64. Rosen MI, Rosenheck RA, Shaner AL, Eckman TA, Gamache GR, Krebs CW. Substance abuse and the need for money management assistance among psychiatric inpatients. Drug Alcohol Depend. 2002;67:331-334.
65. Rosen MI, Rosenheck RA. Substance abuse and the assignment of representative payees. Psychiatr Serv. 1999;50:95-98.
66. Nace EP, Birkmayer F, Sullivan MA, et al. Socially sanctioned coercion mechanisms for addiction treatment. Am J Addict. 2007;16:15-23.
67. Cooper CA, Bartlett SR, Shaaw MA, Yang KK. Drug Courts: 1997 Overview of Operational Characteristics and Implementation Issues. Vol. 1. American University Drug Court Clearinghouse and Technical Assistance Project. Washington, D.C.: Office of Justice Programs, U.S. Department of Justice; 1997.
68. Satel S. Drug treatment: The case for coercion. National Drug Court Institute Review. 2000;3:1-56.
69. American University. Looking at a Decade of Drug Courts. Prepared by the Drug Court Clearinghouse and Technical Assistance Project. Washington, DC: U.S. Department of Justice, Office of Justice Programs; 1999.
70. Farabee D, Prendergast M, Anglin D. The effectiveness of coerced treatment for drug-abusing offenders. Federal Probation. 1998;62:3-10.
71. DeLeon G, Jainchill N. Circumstances, motivation, readiness, and suitability as correlates of treatment tenure. J Psychoactive Drugs. 1986;18:203-208.
72. Hazlehurst KM. Alcohol, outstations and autonomy: An Australian Aboriginal perspective. Journal of Drug Issues. 1986;16:209-220.
73. Bennett LA, Ames GM. The American Experience with Alcohol: Contrasting Cultural Perspectives. New York: Plunum; 1985.
74. Levy JE, Kunitz SJ. Indian Drinking, Navajo Practices and Anglo-American Theories. New York: John Wiley and Sons; 1974.
75. Sargent MJ. Changes in Japanese drinking patterns. Quarterly Journal of Studies on Alcohol. 1967;28:709-722.
76. Caetano R, Suzman RM, Rosen DH, et al. The Shetland Islands: Longitudinal changes in alcohol consumption in a changing environment. British Journal of Addiction. 1983;78:21-36.
77. Rodin AE. Infants and gin mania in 18th century London. JAMA. 1981;245:1237-1239.
78. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642-1652.